Travere Therapeutics, Inc. (TVTX)
44.76
-0.04
(-0.09%)
USD |
NASDAQ |
May 06, 16:00
44.75
-0.01
(-0.02%)
After-Hours: 07:16
Travere Therapeutics Cash from Investing (Quarterly) : 21.55M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | -18.10M |
| Revolution Medicines, Inc. | 74.88M |
| ICU Medical, Inc. | -18.39M |
| Tandem Diabetes Care, Inc. | -14.98M |
| iRhythm Holdings, Inc. | 30.22M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.37M |
| Cash from Financing (Quarterly) | 4.204M |
| Free Cash Flow | -28.94M |
| Free Cash Flow Per Share (Quarterly) | -0.6808 |
| Free Cash Flow to Equity (Quarterly) | -61.47M |
| Free Cash Flow to Firm (Quarterly) | -60.25M |
| Free Cash Flow Yield | -0.69% |